Regional
Region One Metropolitan Ambulance Council
The current listed document is more than 24 months old and may be outdated.
Drugs and doses35
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine, Calcium Chloride, Calcium Gluconate7
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | peds | 0.1 mg/kg | IV | not captured | standing | page 187 |
| Narrow-complex tachycardia | adult | 6–12 mg | IV/IO | not captured | standing | page 187 |
| Wide-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 187 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 188 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 188 |
| Other | adult | 5 mg | NEB | not captured | standing | page 188 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 300 mg | IV/IO | not captured | standing | page 189 |
| Other | peds | 5 mg/kg | IV/IO | not captured | standing | page 189 |
| Post-ROSC care | adult | 150 mg | IV/IO | not captured | standing | page 189 |
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 189 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 160–325 mg | PO | not captured | standing | page 191 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 192 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 192 |
| Organophosphate poisoning | adult | 2 mg | IV/IO | not captured | standing | page 192 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 192 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | page 193 |
| Cardiac arrest | peds | 20 mg/kg | IV/IO | not captured | standing | page 193 |
| Crush injury | adult | 1 g | IV/IO | not captured | standing | page 193 |
| Other | adult | 500–1000 mg | IV/IO | not captured | standing | page 193 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 193 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 4 mL | NEB | not captured | standing | page 194 |
D–F Dexamethasone, Dextrose, Diazepam, Diltiazem, Diphenhydramine, Dopamine, Epinephrine, Etomidate, Fentanyl9
Dexamethasone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 16 mg | IV/IO/IM/PO | not captured | standing | pages 44, 136 |
| Asthma / bronchospasm | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | pages 44, 136 |
| Croup | peds | 0.6 mg/kg | IV/IO/IM/PO | not captured | standing | page 134 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | peds | 1 mL/kg | IV/IO | not captured | standing | page 142 |
| Hypoglycemia | adult | 12.5 g | IV/IO | not captured | standing | pages 48, 49, 141, 142 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | pages 51, 197 |
| Hyperactive delirium | adult | 10 mg | IV/IM | not captured | standing | pages 52, 197 |
| Post-intubation sedation | adult | 5 mg | IV/IM | not captured | standing | pages 41, 197 |
| Seizure | adult | 5 mg | IV/IO/IM | not captured | standing | pages 41, 50, 142, 197 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | pages 41, 50, 142, 197 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 10 mg | IV/IO | not captured | standing | pages 87, 198 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 50 mg | IV/IO/IM | not captured | standing | pages 43, 199 |
| Anaphylaxis | peds | 1 mg/kg | IV/IO/IM | not captured | standing | pages 43, 199 |
| Other | adult | 25–50 mg | IV/IO/IM | not captured | standing | pages 47, 199 |
| Other | adult | 50 mg | IV/IM | not captured | standing | pages 43, 199 |
| Other | peds | 1 mg/kg | IV/IM | not captured | standing | pages 43, 199 |
| Other | peds | 1–2 mg/kg | IV/IO/IM | not captured | standing | pages 47, 199 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 89, 200 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | pages 45, 200 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | pages 43, 137, 201, 202 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | pages 43, 137, 201, 202 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | pages 44, 136, 201, 202 |
| Asthma / bronchospasm | peds | 0.15 mg | IM | not captured | standing | pages 44, 136, 201, 202 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 86, 139, 201, 202 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | pages 84, 133, 201, 202 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | pages 84, 133, 201, 202 |
| CHF / pulmonary edema | adult | 2–20 mcg | IV/IO | not captured | standing | pages 89, 201 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.3 mg/kg | IV/IO | not captured | standing | pages 173, 204 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | pages 88, 205 |
| Other | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | pages 53, 205 |
| Other | adult | 25–50 mcg | IM | not captured | standing | pages 111, 205 |
| Other | adult | 25–50 mcg | IV | not captured | standing | pages 111, 144, 205 |
| Other | peds | 1 mcg/kg | IV | not captured | standing | pages 111, 144, 205 |
| Other | peds | 1–2 mcg/kg | IN | not captured | standing | pages 144, 205 |
| Post-intubation sedation | adult | 25–50 mcg | IV/IO | not captured | standing | pages 41, 205 |
G–L Hydroxycobalamin, Ipratropium, Ketamine, Lidocaine, Lorazepam5
Hydroxycobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | pages 165, 206 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | pages 165, 206 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.5 mg | NEB | not captured | standing | pages 44, 136, 207 |
| Asthma / bronchospasm | peds | 0.5 mg | NEB | not captured | standing | pages 44, 136, 207 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg/kg | IV/IO/IM | not captured | standing | pages 86, 208 |
| Cardiac arrest | adult | 1 mg/kg | IV/IO | not captured | standing | pages 84, 208 |
| Hyperactive delirium | adult | 2 mg/kg | IV | not captured | standing | pages 52, 208 |
| Hyperactive delirium | adult | 4 mg/kg | IM | not captured | standing | pages 52, 208 |
| Other | adult | 25 mg | IV/IO | not captured | standing | pages 111, 208 |
| Other | adult | 50 mg | IM/IN | not captured | standing | pages 111, 208 |
| Other | peds | 0.5 mg/kg | IM/IN | not captured | standing | pages 111, 208 |
| Post-intubation sedation | adult | 2 mg/kg | IV/IO | not captured | standing | pages 41, 208 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 173, 208 |
| RSI induction | adult | 2 mg/kg | IV/IO | not captured | standing | pages 173, 208 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mg/kg | IV | not captured | standing | pages 84, 209 |
| Other | adult | 20–40 mg | IO | not captured | standing | page 209 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2 mg | IV | not captured | standing | pages 51, 210 |
| Hyperactive delirium | adult | 4 mg | IV/IM | not captured | standing | pages 52, 210 |
| Post-intubation sedation | adult | 2–4 mg | IV/IM | not captured | standing | pages 41, 210 |
| Seizure | adult | 2 mg | IV/IO/IM | not captured | standing | pages 50, 142, 210 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 50, 142, 210 |
M–O Magnesium Sulfate, Methylprednisolone, Metoprolol, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Ondansetron, Oral Glucose10
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | pages 31, 44, 211 |
| Asthma / bronchospasm | peds | 50 mg/kg | IV/IO | not captured | standing | pages 31, 44, 211 |
| Cardiac arrest | adult | 2 g | IV/IO | not captured | standing | page 211 |
| Cardiac arrest | peds | 50 mg/kg | IV/IO | not captured | standing | page 211 |
| Eclampsia / pre-eclampsia | adult | 10 g | IM | not captured | standing | pages 50, 59, 211 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | pages 31, 59, 211 |
| VF / pulseless VT | adult | 1–2 g | IV/IO | not captured | standing | pages 31, 87, 138, 211 |
| VF / pulseless VT | peds | 50 mg/kg | IV/IO | not captured | standing | pages 31, 87, 138, 211 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 29, 213 |
| Allergic reaction | adult | 125 mg | IV/IO/IM | not captured | standing | pages 43, 213 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | pages 43, 213 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 43, 213 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO/IM | not captured | standing | pages 44, 136, 213 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO/IM | not captured | standing | pages 44, 136, 213 |
Metoprolol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV/IO | not captured | standing | pages 87, 214 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2.5–5 mg | IV/IM/IN | not captured | standing | pages 51, 215 |
| CHF / pulmonary edema | adult | 2.5 mg | IV/IO/IM | not captured | standing | pages 89, 215 |
| Hyperactive delirium | adult | 5 mg | IV/IM | not captured | standing | pages 52, 215 |
| Post-intubation sedation | adult | 5 mg | IV/IO/IM | not captured | standing | pages 41, 215 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | pages 86, 215 |
| Procedural sedation | adult | 2.5–5 mg | IV/IO/IN | not captured | standing | pages 87, 215 |
| Seizure | adult | 10 mg | IM | not captured | standing | pages 50, 215 |
| Seizure | adult | 2.5 mg | IV/IO | not captured | standing | pages 50, 215 |
| Seizure | peds | 0.1 mg/kg | IV/IO | not captured | standing | pages 50, 215 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | pages 50, 215 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–4 mg | IV/IO/IM | not captured | standing | pages 88, 217 |
| Other | adult | 2–4 mg | IV/IO/IM | not captured | standing | pages 111, 144, 217 |
| Other | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 111, 144, 217 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 2 mg | IV/IO | not captured | standing | pages 47, 218 |
| Cardiac arrest | peds | 1–2 mg | IV/IO | not captured | standing | pages 47, 218 |
| Opioid overdose | adult | 0.5–2 mg | IV/IO/IM | not captured | standing | pages 47, 218 |
| Opioid overdose | adult | 2–4 mg | IN | not captured | standing | pages 47, 218 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | pages 47, 218 |
| Opioid overdose | peds | 0.1 mg/kg | IN | not captured | standing | pages 47, 218 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | pages 88, 219 |
| ACS / chest pain | adult | 1 inch | TD | not captured | standing | pages 88, 219 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | pages 89, 219 |
| CHF / pulmonary edema | adult | 1 inch | TD | not captured | standing | pages 89, 219 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–12 mcg | IV/IO | not captured | standing | pages 85, 89, 220 |
| Hypotension / shock | adult | 2–12 mcg | IV/IO | not captured | standing | pages 45, 85, 140, 220 |
| Post-ROSC care | adult | 2–12 mcg | IV/IO | not captured | standing | pages 85, 220 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 4 mg | IV | not captured | standing | pages 88, 222 |
| Nausea / vomiting | adult | 4 mg | IV/IO/PO | not captured | standing | page 222 |
| Nausea / vomiting | peds | 2 mg | IV/IO/PO | not captured | standing | pages 143, 222 |
| Other | adult | 4 mg | IV/IO/PO | not captured | standing | pages 53, 222 |
| Other | adult | 4 mg | IV/IO/IM | not captured | standing | pages 111, 222 |
| Other | adult | 4 mg | IV/IO | not captured | standing | pages 173, 222 |
| Post-intubation sedation | adult | 4 mg | IV/IO | not captured | standing | pages 40, 222 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | pages 48, 223 |
| Hypoglycemia | peds | 15 g | PO | not captured | standing | pages 48, 223 |
P–R Rocuronium1
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1.2 mg/kg | IV/IO | not captured | standing | pages 173, 224 |
S–Z Sodium Bicarbonate, Succinylcholine, Tranexamic Acid3
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 225 |
| Hyperactive delirium | adult | 100 mEq | IV/IO | not captured | standing | pages 52, 225 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 225 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 225 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 225 |
| Other | adult | 1–2 mEq/kg | IV/IO | not captured | standing | page 225 |
| Other | adult | 1–2 mEq/kg | IV/IO | not captured | standing | pages 47, 225 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 225 |
| Tricyclic overdose | adult | 1–2 mEq/kg | IV/IO | not captured | standing | pages 47, 225 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 mg/kg | IV/IO | not captured | standing | pages 173, 227 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV/IO | not captured | standing | page 228 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | pages 109, 228 |
Cite this
Region One Metropolitan Ambulance Council, United States EMS Protocol Census. 140 dose entries, effective 2021-03-01.
https://protoquiz.com/census/agencies/region-one-metropolitan-ambulance-council/
The census is free and not for sale. Only public agencies are named.